Close Menu

CE sequencing

The firm plans to submit an EUA application for its quantitative Sanger sequencing COVID-19 test, which could run on hundreds of available CE instruments.

While molecular testing is now routine in cancer and women's health, for other disease areas, the technology may be overkill, Sundin said.